pasitheaclinics.com (KTTA) Stock Quotes

pasitheaclinics.com - graphic logo of issuer KTTA

Drug development for severe brain pathologies is in its early stages, requiring constant funding and increasing research costs, with the indicator standing at 0.51. The market dynamics of Pasithea Therapeutics (KTTA) help track these processes. Pasithea Therapeutics (KTTA) is developing psychiatric medications while optimizing component procurement to ensure operational stability. Meanwhile, the business faces intense pressure from industry behemoths.

Pasithea Therapeutics - KTTA Price (period 07/04/2022 - 11/15/2026)

Pasithea Therapeutics (KTTA) - metric breakdowns and financial figures

- stock value and consensus price forecast:
Analysis of all company metrics:Pasithea Therapeutics Corp KTTA
Signature product of Pasithea

Pasithea Therapeutics (KTTA) developments in neuroimmunology remain independent of macroeconomic factors, as the business valuation is determined exclusively by the success of clinical trials for schizophrenia drugs. The price captures the market value of a single share in dollars, reflecting through trading dynamics the balance between investor expectations for medical breakthroughs and the asset's current exchange liquidity.

Analysis of competing companies

Stock Price BIIB|Neurocrine Biosciences, Inc. - Share Price|Stock Price RGC (Regencell Bioscience Ltd)|AXSM: Share Price|ACADIA Corp - Stock Price|XENE (Xenon Pharmaceuticals) - Share Price|VKTX (Viking Pharma) - Stock Quotes|Share Price SUPN|Price Chart Catalyst Pharmaceuticals|Share Price DNLI (Denali Therapeutics Inc)|Stock Price HRMY|BHVN - Market Price|amylyx.com - Stock Quotes|Stock Price Trevi Therapeutics Inc TRVI|PRAX - Price Chart|Price Performance Chart AVXL (Anavex Life Sciences Corp)|CeriBell Inc (CBLL) - Price Chart|Market Price Prothena Corp (PRTA)|ALEC (Alector Therapeutics) - Stock Price|Stock Price Annexon Biosciences|Price Chart Omeros Corp (OMER)|NGNE - Market Price|AC Immune - Stock Quotes|Voyager Therapeutics (VYGR) - Market Price|NMRA - Price Chart|SCLX: Price Chart|TVGN: Stock Price|Alpha Cognition (ACOG) - Stock Price|Stock Quotes CGTX|Stock Price Inhibikase Therapeutics|Stock Price SAVA|Market Chart Assertio Holdings|Stock Price COYA (Coya Therapeutics)|VTGN: Share Price|OVID - Price Chart|Price Performance Chart ABOS (Acumen Pharmaceuticals)|CRVO: Stock Price|ATHE: Price|CLNN (clene.com) - Stock Price|pepgen.com (PEPG) - Market Chart|Price Chart Jupiter Neurosciences Inc (JUNS)|RLMD (Relmada Therapeutics) - Price Performance Chart|Stock Price ANVS (Annovis Bio Inc)|gracetx.com (GRCE) - Market Price|AIFF - Price Chart|anewmeds.com (KLTO) - Stock Quotes|NeuroSense Therapeutics, Ltd. (NRSN) - Price Chart|Market Price Reviva Pharmaceuticals Holdings, Inc. (RVPH)|Price Chart MetaVia|Share Price NRXS (NeurAxis Inc.)|Stock Price HSDT|PASG: Quote Chart|Neuphoria Therapeutics, Inc. - Stock Quotes|NERV: Share Price|athira.com - Stock Price|ADXN - Stock Price|ALZN: Stock Price|CYCN - Market Chart|PTIX (Protagenic Therapeutics, Inc.) - Stock Price|Stock Price cortigent.com|Stock Quotes ATXI (Avenue Therapeutics, Inc)|Stock Price Brainstorm Cell Therapeutics Inc. (BCLI)|Stock Price CARA (Cara Therapeutics Inc)|Market Chart Chromocell Therapeutics Corporation (CHRO)|Eliem - Stock Price|Market Chart intracellulartherapies.com ITCI|Longboard Pharmaceuticals Inc (LBPH) - Price Chart|Marinus Pharmaceuticals Inc - Price Performance Chart|Price Chart NKGen|Price Chart NRBO|Price Chart Sage Therapeutics (SAGE)|Market Chart Synaptogenix|Stock Price TRVN (trevena.com)|Vigil Neuro - Price Chart|Anew Medical Inc. - Stock Price|Market Price Cerevel